Cargando…
Interdisciplinary Treatment of Malignant Chest Wall Tumors
Background: Chest wall resections for malignant chest wall tumors (MCWTs), particularly those with full-thickness chest wall involvement requiring reconstruction, present a therapeutic challenge for thoracic and plastic reconstructive surgeons. The purpose of this study was to review our experience...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532685/ https://www.ncbi.nlm.nih.gov/pubmed/37763172 http://dx.doi.org/10.3390/jpm13091405 |
_version_ | 1785112019043614720 |
---|---|
author | Khamitov, Koblandy Dudek, Wojciech Arkudas, Andreas Haj Khalaf, Mohamed Parjiea, Chirag Higaze, Mostafa Horch, Raymund E. Sirbu, Horia |
author_facet | Khamitov, Koblandy Dudek, Wojciech Arkudas, Andreas Haj Khalaf, Mohamed Parjiea, Chirag Higaze, Mostafa Horch, Raymund E. Sirbu, Horia |
author_sort | Khamitov, Koblandy |
collection | PubMed |
description | Background: Chest wall resections for malignant chest wall tumors (MCWTs), particularly those with full-thickness chest wall involvement requiring reconstruction, present a therapeutic challenge for thoracic and plastic reconstructive surgeons. The purpose of this study was to review our experience with chest wall resection for primary and metastatic MCWTs, with a focus on perioperative outcomes and postoperative overall survival (OS). Methods: All patients who underwent surgical resection for primary and secondary MCWTs at our single institution between 2000 and 2019 were retrospectively analyzed. Results: A total of 42 patients (25 male, median age 60 years) operated upon with curative (n = 37, 88.1%) or palliative (n = 5, 11.9%) intent were reviewed. Some 33 (78%) MCWTs were of secondary origin. Chest wall reconstruction was required in 40 (95%) cases. A total of 13 (31%) patients had postoperative complications and one (2.3%) died perioperatively. The 5-year postoperative overall survival rate was 51.9%. The postoperative 5-year survival rate of 42.6% in patients with secondary MCWTs was significantly lower compared to the figure of 87.5% in patients with primary MCWTs. Conclusions: In well-selected patients, chest wall resections for primary and secondary MCWTs are feasible and associated with good perioperative outcomes. For secondary MCWTs, surgery can also be performed with palliative intent. |
format | Online Article Text |
id | pubmed-10532685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105326852023-09-28 Interdisciplinary Treatment of Malignant Chest Wall Tumors Khamitov, Koblandy Dudek, Wojciech Arkudas, Andreas Haj Khalaf, Mohamed Parjiea, Chirag Higaze, Mostafa Horch, Raymund E. Sirbu, Horia J Pers Med Article Background: Chest wall resections for malignant chest wall tumors (MCWTs), particularly those with full-thickness chest wall involvement requiring reconstruction, present a therapeutic challenge for thoracic and plastic reconstructive surgeons. The purpose of this study was to review our experience with chest wall resection for primary and metastatic MCWTs, with a focus on perioperative outcomes and postoperative overall survival (OS). Methods: All patients who underwent surgical resection for primary and secondary MCWTs at our single institution between 2000 and 2019 were retrospectively analyzed. Results: A total of 42 patients (25 male, median age 60 years) operated upon with curative (n = 37, 88.1%) or palliative (n = 5, 11.9%) intent were reviewed. Some 33 (78%) MCWTs were of secondary origin. Chest wall reconstruction was required in 40 (95%) cases. A total of 13 (31%) patients had postoperative complications and one (2.3%) died perioperatively. The 5-year postoperative overall survival rate was 51.9%. The postoperative 5-year survival rate of 42.6% in patients with secondary MCWTs was significantly lower compared to the figure of 87.5% in patients with primary MCWTs. Conclusions: In well-selected patients, chest wall resections for primary and secondary MCWTs are feasible and associated with good perioperative outcomes. For secondary MCWTs, surgery can also be performed with palliative intent. MDPI 2023-09-20 /pmc/articles/PMC10532685/ /pubmed/37763172 http://dx.doi.org/10.3390/jpm13091405 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Khamitov, Koblandy Dudek, Wojciech Arkudas, Andreas Haj Khalaf, Mohamed Parjiea, Chirag Higaze, Mostafa Horch, Raymund E. Sirbu, Horia Interdisciplinary Treatment of Malignant Chest Wall Tumors |
title | Interdisciplinary Treatment of Malignant Chest Wall Tumors |
title_full | Interdisciplinary Treatment of Malignant Chest Wall Tumors |
title_fullStr | Interdisciplinary Treatment of Malignant Chest Wall Tumors |
title_full_unstemmed | Interdisciplinary Treatment of Malignant Chest Wall Tumors |
title_short | Interdisciplinary Treatment of Malignant Chest Wall Tumors |
title_sort | interdisciplinary treatment of malignant chest wall tumors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532685/ https://www.ncbi.nlm.nih.gov/pubmed/37763172 http://dx.doi.org/10.3390/jpm13091405 |
work_keys_str_mv | AT khamitovkoblandy interdisciplinarytreatmentofmalignantchestwalltumors AT dudekwojciech interdisciplinarytreatmentofmalignantchestwalltumors AT arkudasandreas interdisciplinarytreatmentofmalignantchestwalltumors AT hajkhalafmohamed interdisciplinarytreatmentofmalignantchestwalltumors AT parjieachirag interdisciplinarytreatmentofmalignantchestwalltumors AT higazemostafa interdisciplinarytreatmentofmalignantchestwalltumors AT horchraymunde interdisciplinarytreatmentofmalignantchestwalltumors AT sirbuhoria interdisciplinarytreatmentofmalignantchestwalltumors |